Archives: Sponsors

Windes

|

January 19, 2016

|

« Previous 1 2 3

Or Search Our Site By Topic:

adenocarcinoma Advocacy advocacy ALK+ awareness biomarker biomarker testing chemotherapy clinical trial Clinical Trials clinical trials combination therapy Detection Diagnosis diagnosis early detection EGFR EGFR mutation genomic testing immunotherapy Immunotherapy KRAS latest research Living with Lung Cancer Lung Cancer Info lung cancer research non-smoker NSCLC patient support personalized medicine radiation Research ROS-1 positive ROS1 SCLC small cell lung cancer speakers bureau stage 4 Survivors Targeted therapy targeted therapy Treatment treatment Tributes Uncategorized

More

About Us
About Lung Cancer
Research
Living with Lung Cancer
Get Involved

Give with Confidence

Our Mission

LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials.

Latest In Research

11/15
2023

FDA Approves Repotrectinib for Locally Advanced or Metastatic ROS1+ NSCLC

The FDA has approved repotrectinib (Augtyro) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer. SUMMARY: The Food and Drug Administration (FDA) recently approved a new dru…

Sign up

Get the latest news about lung cancer research.

Connect with us

Sponsors | Legal and Privacy | Media Contact | State Fundraising Notices